FMR CORP 13D and 13G filings for PTC Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-10 08:53 am Sale |
2024-01-09 | 13G | PTC Therapeutics, Inc. PTCT |
FMR CORP | 1,814,421 2.404% |
-4,617,429 (-71.79%) |
Filing |
| 2023-11-13 09:02 am Sale |
2023-11-10 | 13G | PTC Therapeutics, Inc. PTCT |
FMR CORP | 6,431,850 8.523% |
-4,350,456 (-40.35%) |
Filing |
| 2023-02-09 12:31 pm Purchase |
2023-02-09 | 13G | PTC Therapeutics, Inc. PTCT |
FMR CORP | 10,782,306 14.999% |
177,621 (+1.67%) |
Filing |
| 2022-02-09 10:24 am Purchase |
2022-02-08 | 13G | PTC Therapeutics, Inc. PTCT |
FMR CORP | 10,604,685 15.000% |
365,530 (+3.57%) |
Filing |
| 2021-02-08 10:31 am Purchase |
2021-02-05 | 13G | PTC Therapeutics, Inc. PTCT |
FMR CORP | 10,239,155 14.999% |
3,519,111 (+52.37%) |
Filing |
| 2020-07-10 11:38 am Purchase |
2020-07-09 | 13G | PTC Therapeutics, Inc. PTCT |
FMR CORP | 6,720,044 10.541% |
4,271,902 (+174.50%) |
Filing |